This is an outdated version published on 2021-12-16. Read the most recent version.

Impact of COVID-19 Lockdown on Depression Severity and the Use of Drugs Among University of Ibadan Students

Authors

  • Abdulhammed Opeyemi Babatunde Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan; Healthy Africans Platform, Ibadan, Nigeria
  • Dimeji AbdulSobur Olawuyi Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Habib Ayomide Shobanke Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Adeniyi Abraham Adesola Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Christabel Ijeoma Uche-Orji Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Boluwatife Adefunke Bolatito Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Yeshua Ayokun Adedeji Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • AbdulSobur Olatunde Abdulazeez Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Lordstrong Akano Olaniyi Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Dolapo Michael Babalola Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria

DOI:

https://doi.org/10.5195/ijms.2021.837

Keywords:

depression, COVID-19, Drug abuse, students, mental health

Abstract

Background: Since the declaration of COVID-19 as a pandemic, measures such as nationwide lockdowns have been implemented. The sudden disruption of activities coupled with fear could trigger or aggravate mental illnesses and consequently, increase substance use as a coping mechanism. This study then sought to assess the impact of the lockdown on depression and substance use amongst students in a tertiary institution in Ibadan city, Nigeria.

Methods: A self-administered 26 questions online questionnaire was employed for data collection of socio-demographic characteristics, Patient Health Questionnaire (PHQ-9) to assess depression, and a section on use of psychoactive drug during lockdown. Data were statistically analyzed using IBM's SPSS and Microsoft Excel.

Results: We gathered 102 responses, 54.9% were males. Most of the respondents had mild depression (41.2%), followed by 36.3% that reported not having an episode of depression, 15.7% moderate, 4.9% moderately severe and 2% severe depression. Females had more depressive episodes than the males (p=0.185). Only 4% reported substance use since the pandemic, all were male. At a 95% confidence interval, there was no significant association between the level of depression and any socio-demographic characteristics of students and between the level of depression and drug use.

Conclusions: According to this study, lockdown and other mitigation strategies implemented during the pandemic were not found to be associated with drug use. A limitation of this study is the cross-sectional design, as a result, a larger multicenter study is needed to ascertain the possible association between lockdown, depressive symptoms, and drug use among students.

Metrics

Metrics Loading ...

References

1. Abdullahi A, Aiyenuro A, Ogunsola S, Adesewa V, Zakariyah M. Risk of COVID-19 on diabetes mellitus and hypertension. Preprints. 2020; 2020090029: http://doi:10.20944/preprints2020090029.v1
2. Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020;16:57. http://doi.org/10.1186/s12992-020-00589-w
3. World Health Organization Regional Office for Europe. http://www.euro.who.int/. Accessed September 2020.
4. Zhang Y, Ma ZF. Impact of COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province China: a cross sectional study. IJERPH. 2020. 17(7): http://doi.org/10.3390/ijerph17072381
5. Mazza C, Ricci E, Biondi S, Colasanti M, Ferracuti S, Napoli C, et al. IJERPH. 2020;17(9), 3165: https://doi.org/10.3390/ijerph17093165
6. Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Lancet Psychiatry. 2020;7: 547-60: https://doi.org/10.1016/S2215-0366(20)30168-1
7. Ethman CK, Abdalla SM, Cohen GH, et al. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Network Open. 2020;3(9):e2019686: https://doi:10.1001/jamanetworkopen.2020.19686
8. Reem A, Khalid A, Abdullahi A, AbdulHameed A. Depression and anxiety among high school students at Qassim region. J Family Prim Care. 2019;8:504-510. http://doi:10.4103/jfmpc.jfmpc_383_18
9. Gulf Bend Center. Substance/Medication-Induced Depressive disorder. https://www.gulfbend.org/poc/view_doc.php?type=doc&id=12981&en=
10. Smith K. PSYCOM. Substance abuse and Depression. https://www.psycom.net/depression-substance-abuse. Updated November 2018. Accessed September 2020.
11. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;(9):606-13
12. Cameron IM, Crawford JR, Lawton K, et al. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Pract. 2008;58(546):32-6. doi: 10.3399/bjgp08X263794
13. Islam MA, Barna SD, Raihan H, Khan MNA, Hossain MT. Depression and anxiety among university students during the COVID-19 pandemic in Bangladesh: A web-based cross-sectional survey. PLoS One. 2020;15(8):e0238162. doi: 10.1371/journal.pone.0238162.
14. Elvira L, Francisco FC, Rico-Uribe LA, Beatriz O, Josep MH, Ayuso-Mateos JL, et al. Are lonliness and social isolation associated with cognitive decline? International Jounal of Geriatric Psychiatry. 2019. https://doi.org/10.1002/gps.5174.
15. Altena E et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. Journal of Sleep Research. 2020;29(4) doi: 10.1111/jsr.13052.
16. Li Y, Qin Q, Sun Q, Sanford LD, Vgontzas AN, Tang X. Insomnia and psychological reactions during the COVID-19 outbreak in China. J. Clin. Sleep Med. 2020. doi: 10.5664/jcsm.8524.
17. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020:288. doi: 10.1016/j.psychres.2020.112954.
18. Solomou I, Constantinidou F. Prevalence and Predictors of Anxiety and Depression Symptoms during the COVID-19 Pandemic and Compliance with Precautionary Measures: Age and Sex Matter. Int. J. Environ. Res. Public Health. 2020;17(14). doi: 10.3390/ijerph17144924.
19. McCullough ME, Larson DB. Religion and depression: a review of the literature. Twin Res. 1999;2(2):126–136. doi: 10.1375/twin.2.2.126.
20. Vasegh S, Mohammadi MR. Religiosity, anxiety, and depression among a sample of iranian medical students. Int. J. Psychiatry Med. 2007;37(2):213–227. doi: 10.2190/J3V5-L316-0U13-7000.
21. Gureje O, Lasebikan VO, Ephraim-Oluwanuga O, Olley BO, Kola L. Community study of knowledge of and attitude to mental illness in Nigeria. British Journal of Psychiatry. 2005;186 (May): 436–441. doi: 10.1192/bjp.186.5.436.
22. Meo SA, Abukhalaf AA, Alomar AA, Sattar K, Klonoff DC. COVID-19 Pandemic: Impact of Quarantine on Medical Students' Mental Wellbeing and Learning Behaviors. Pak J Med Sci. 2020;36(COVID19-S4):S43-S48. doi:10.12669/pjms.36.COVID19-S4.2809
23. Blasi MD, Giardina A, Giordano C, et al. Problematic video game use as an emotional coping strategy: Evidence from a sample of MMORPG gamers. J Behav Addict. 2019;8(1):25-34. doi:10.1556/2006.8.2019.02
24. Jacobs DF. A general theory of addictions: A new theoretical model. J Gambling Stud. 1986;2:15–31. Doi:10.1007/BF01019931
25. Khantzian EJ. Addiction as a self-regulation disorder and the role of self-medication. Addiction. 2013;108(4):668-669. doi:10.1111/add.12004
26. Király O, Urbán R, Griffiths MD, et al. The mediating effect of gaming motivation between psychiatric symptoms and problematic online gaming: an online survey. J Med Internet Res. 2015;17(4):e88. Published 2015 Apr 7. doi:10.2196/jmir.3515
27. King DL, Delfabbro PH, Billieux J, Potenza MN. «Problematic online gaming and the COVID-19 pandemic». J Behav Addict. 2020;9(2):184-186. Published 2020 Apr 29. doi:10.1556/2006.2020.00016
28. Ko C.H., Yen J.-Y. 2020. «Impact of COVID-19 on gaming disorder: monitoring and prevention». Journal of Behavioral Addictions
29. Mestre-Bach G., Blycker G., Potenza M. «Pornography use in the setting of the COVID-19 pandemic». J Behav Addict. 2020 doi: 10.1556/2006.2020.00015.
30. Abrahao KP, Salinas AG, Lovinger DM. «Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits». Neuron.2017;96(6):1223-1238. doi:10.1016/j.neuron.2017.10.032
31. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231-244. doi:10.3109/10673229709030550
32. Zato?ski WA, Wojty?a A. From the editors. Journal of Health Inequalities. 2019;5(2):121-121. doi:10.5114/jhi.2019.91379
33. Chodkiewicz J, Talarowska M, Miniszewska J, Nawrocka N, Bilinski P. Alcohol Consumption Reported during the COVID-19 Pandemic: The Initial Stage. Int J Environ Res Public Health. 2020;17(13):4677. Published 2020 Jun 29. doi:10.3390/ijerph17134677
34. Sasha R., Kat M., Talia S., Catherine K., Micheal H., Kseniia G., et al.. Depression and Anxiety During the COVID-19 Pandemic in an Urban, Low-Income Public University Sample. Journal of Traumatic Stress. 2020, 00,1-11. https://doi.org/10.1002/jts.22600.

Downloads

Published

2021-12-16

Versions

How to Cite

Babatunde, A. O., Olawuyi, D. A. ., Shobanke, . H. A., Adesola, A. A. ., Uche-Orji, C. I. ., Bolatito, B. A. ., Adedeji, Y. A. ., Abdulazeez, A. O. ., Olaniyi, L. A. ., & Babalola, D. M. . (2021). Impact of COVID-19 Lockdown on Depression Severity and the Use of Drugs Among University of Ibadan Students. International Journal of Medical Students, 9(4). https://doi.org/10.5195/ijms.2021.837

Issue

Vol. 9 No. 4 (2021)

Section

Original Article

License

Copyright (c) 2020 Abdulhammed Opeyemi Babatunde, Dimeji AbdulSobur Olawuyi, Habib Ayomide Shobanke, Adeniyi Abraham Adesola, Christabel Ijeoma Uche-Orji, Boluwatife Adefunke Bolatito, Yeshua Ayokun Adedeji, AbdulSobur Olatunde Abdulazeez, Lordstrong Akano Olaniyi, Dolapo Michael Babalola

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.